The IPO Buzz: Scribe Therapeutics Prices IPO at $15 – High End – & Stock Pops Almost 67 Percent
Scribe Therapeutics (SCTX) upsized its IPO at pricing to 8.58 million shares – up from 7.15 million in the prospectus – and priced the deal at $15.00 – the top of its range – to raise $128.7 million on Thursday night, July 23, 2026. Scribe’s stock jumped nearly 67 percent - opening at $25.00 - up $10.00 from its IPO price in its NASDAQ debut ahead of noon EDT on Friday, July 24. ..
Read more July 23, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Market Technology Acquisition Corp. | MTAKU | 20.0 | $ 200.0 mil | 7/24/2026 Priced | S/O | S/O |
| Pelican Acquisition Corp. II | PLCIU | 7.5 | $ 75.0 mil | 7/24/2026 Priced | S/O | S/O |
| Scribe Therapeutics, Inc. | SCTX | 8.6 | $ 128.7 mil | 7/24/2026 Priced | S/O | S/O |
Last 100 IPOs - July 23, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 54 |
| Number Down: | 43 |
| Number Unchanged: | 3 |
| Percentage Change From Issue Price: | 6.01% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - July 23, 2026
| Number of IPOs priced (Excluding 131 units) : | 98 |
| Number Up: | 53 |
| Number Down: | 42 |
| Number Unchanged: | 3 |
| Total Return From Issue Price: | 5.66% |
| The Nasdaq Composite Index YTD % Change | 35.22% |